The global protein expression market is expected to grow at a CAGR of 8.83% between 2013 and 2018, to reach $1,396.68 million by 2018.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast), by
Products (Expression Vector, Service, Reagent), by Application
(Industrial, Therapeutic) by End User (Pharmaceutical, Biotechnology,
CRO) - Global Forecast to 2018.
Publish Date:- April 2014.
The “Protein Expression Market by Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast), by
Products (Expression Vector, Service, Reagent), by Application (Industrial, Therapeutic) by End User
(Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018”provides a detailed overview of the major drivers,
restraints, challenges, opportunities, current market trends, and strategies impacting the global protein expression
market along with the estimates and forecasts of the revenue and share analysis.
Browse 111 market data Tables and 36 Figures spread through 280 Pages and in-depth TOC on "Protein
Expression Market by Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast), by Products
(Expression Vector, Service, Reagent), by Application (Industrial, Therapeutic) by End User (Pharmaceutical,
Biotechnology, CRO) - Global Forecast to 2018"
Early buyers will receive 10% customization on reports.
The global protein expression market is expected to grow at a CAGR of 8.83% between 2013 and 2018, to reach
$1,396.68 million by 2018.
The report segments this market by expression systems, products, applications, and end users. The expression system
segment includes insect, mammalian, prokaryotic, yeast, and others. Of these, the prokaryotic segment commanded the
largest share of the global market, by expression in 2013. The use of E.coli as the preferred host cell for large quantity
and cheap protein expression and production has accounted for the highest share of prokaryotic expression systems.
The mammalian segment is poised to grow at the highest CAGR between 2013 and 2018. With the rise in demand for
therapeutic proteins, the need for proteins with appropriate post-translational modifications will increase, thus driving the
speedy growth of the mammalian expression systems.
The product segments included in this report are competent cells, expression vectors, instruments, reagents, and
services. The reagents segment commanded the largest share of the global market in 2013, while the services segment
is poised to grow at the highest CAGR between 2013 and 2018. Since chemical transfection is easier and less
expensive, chemical reagents are used for transfections and maintenance of cell lines in large numbers. Also, the large
numbers of reagents in the markets is because the consumption of reagents is a recurring event as opposed to the
relatively less consumption of vectors and competent host cells. As companies have now started to offer services that
provide custom optimization of protein expression, emerging research labs and companies who lack resources and
expertise will be highly benefitted. Since the market is expected to grow at a CAGR of 8.83% between 2013 and 2018,
the increasing need will boost the growth of the services offered by companies.
Download free PDF Brochure:-http://www.marketsandmarkets.com/pdfdownload.asp?id=180323924
The applications segment of the protein expression market includes industrial proteins, research applications, and
therapeutic proteins. Of these, therapeutic proteins segment commanded the largest share of the global market in 2013
and is also poised to grow at the highest CAGR between 2013 and 2018. Therapeutic proteins serve a highly specific
and complex set of functions that cannot be mimicked by simple chemical compound. Therapeutic proteins have higher
immuntolerance and are ideally suited therapeutic candidates. Owing to the versatile advantages of therapeutic proteins
over small molecule drugs to alleviate diseases, the therapeutic proteins application is expected to continue growing at
the highest CAGR.
The end-user segments included in this report are academic research, contract research organizations, pharmaceutical
and biotechnological companies, and others. Of these, the pharmaceutical and biotechnological companies segment
commanded the largest share of the global protein expression market in 2013, while the contract research organizations
segment is poised to grow at the highest CAGR between 2013 and 2018. Protein expression finds primary application in
the research and development of commercial proteins for use in pharmaceuticals and biotechnology. As such,
pharmaceutical and biotechnological companies hold the highest share of global market. With the increasing
outsourcing by pharmaceutical and biotechnological companies and the lack of resources and expertise in the emerging
pharmaceutical companies, contract research organizations which provide relatively less expensive resources and
expertise are expected to grow at the highest CAGR.
Ask For Sample Report:-http://www.marketsandmarkets.com/requestsample.asp?id=180323924
Based on geography, the global protein expression market is segmented into Asia, Europe, North America, and Rest of
the World (RoW). The Asia segment includes the regional segments of China, India, Japan, and Rest of Asia (RoA).
The Europe segment is further divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the
Rest of Europe (RoE). North America is further divided into regional segments of Canada and U.S. The Rest of the
World (RoW) segment is further divided into the regional segments of Latin America, Middle East and Africa, and Pacific
The global market is expected to grow at a CAGR of 8.83% between 2013 and 2018, to reach $1,396.68 million in 2018.
Protein expression is an integral part of proteomics that facilitates research by allowing the expression of genetically
engineered recombinant proteins in a diverse range of host cells. On account of the decreasing R&D productivity and
the patent cliff sales drop, increasing research intensity in the pharmaceutical sector will be an important growth driver
for this market during the forecast period between 2013 and 2018. In addition, the growth in the biologics and
proteomics market will enhance the research in protein expression, thus enabling it to be a major growth driver.
However, the decline in R&D expenditure and the high consolidation in the market are restraining the market.
The major players in the protein expression market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories (U.S.),
Life Technologies Corporation (U.S.), Merck Millipore (U.S.), New England Biolabs, Inc. (U.S.), Promega Corporation
(U.S.), QIAGEN (Netherlands), Sigma-Aldrich Corporation (U.S.), Takara Bio, Inc. (Japan), and Thermo Fisher
Scientific, Inc. (U.S.).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically
analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation,
banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages,
industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: [email protected]